Literature DB >> 21234532

[Interventional bronchoscopy in lung cancer].

A Bergner1, R M Huber.   

Abstract

Stenosis of central airways or hemoptysis are classical indications for interventional bronchoscopy in lung cancer. In the case of endoluminal tumor growth cryo-, laser- or brachytherapy are widely used. In the case of airway stenosis due to compression by extraluminal tumor masses balloon-dilatation and/or stenting and - with delayed effect - brachytherapy are first-choice therapies. Carcinoma in situ and early stage tumors can be treated curatively with brachytherapy or photodynamic therapy. Recently introduced bronchoscopic techniques like electro-magnetic navigation may result in new curative options for peripheral lung tumors.

Entities:  

Mesh:

Year:  2011        PMID: 21234532     DOI: 10.1007/s00108-010-2699-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  15 in total

1.  Electromagnetically navigated brachytherapy as a new treatment option for peripheral pulmonary tumors.

Authors:  Wolfgang Harms; Robert Krempien; Christian Grehn; Frank Hensley; Jürgen Debus; Heinrich D Becker
Journal:  Strahlenther Onkol       Date:  2006-02       Impact factor: 3.621

Review 2.  Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers.

Authors:  J-M Vergnon; R M Huber; K Moghissi
Journal:  Eur Respir J       Date:  2006-07       Impact factor: 16.671

3.  Nd:YAG laser resection of lung cancer invading the airway as a bridge to surgery and palliative treatment.

Authors:  Federico Venuta; Erino A Rendina; Tiziano De Giacomo; Edoardo Mercadante; Federico Francioni; Francesco Pugliese; Marco Moretti; Giorgio F Coloni
Journal:  Ann Thorac Surg       Date:  2002-10       Impact factor: 4.330

4.  Diagnosis and treatment of early lung cancer: as it stands today.

Authors:  Francis D Sheski; Praveen N Mathur
Journal:  Semin Respir Crit Care Med       Date:  2004-08       Impact factor: 3.119

5.  Risk factors for massive hemoptysis after endobronchial brachytherapy in patients with tracheobronchial malignancies.

Authors:  R Hara; J Itami; T Aruga; T Kozuka; K Nakajima; H Yamashita; T Uno; T Morita; H Itoh; T Nomura
Journal:  Cancer       Date:  2001-11-15       Impact factor: 6.860

Review 6.  Cryotherapy for tracheobronchial disorders.

Authors:  M O Maiwand; J P Homasson
Journal:  Clin Chest Med       Date:  1995-09       Impact factor: 2.878

Review 7.  'Heat and destroy': bronchoscopic-guided therapy of peripheral lung lesions.

Authors:  Ralf Eberhardt; Nicolas Kahn; Felix J F Herth
Journal:  Respiration       Date:  2010-02-10       Impact factor: 3.580

8.  Comparative study of three different catheters for CT imaging-bronchoscopy-guided radiofrequency ablation as a potential and novel interventional therapy for lung cancer.

Authors:  Tsuyoshi Tanabe; Tomonobu Koizumi; Kenji Tsushima; Michiko Ito; Shintaro Kanda; Takashi Kobayashi; Masanori Yasuo; Yoshitaka Yamazaki; Keishi Kubo; Takayuki Honda; Ryouichi Kondo; Kazuo Yoshida
Journal:  Chest       Date:  2009-10-26       Impact factor: 9.410

9.  Electromagnetic navigation bronchoscopy-guided fiducial placement for robotic stereotactic radiosurgery of lung tumors: a feasibility study.

Authors:  Devanand Anantham; David Feller-Kopman; Lakshmi N Shanmugham; Stuart M Berman; Malcolm M DeCamp; Sidhu P Gangadharan; Ralf Eberhardt; Felix Herth; Armin Ernst
Journal:  Chest       Date:  2007-07-23       Impact factor: 9.410

10.  Palliative endobronchial brachytherapy for central lung tumors. A prospective, randomized comparison of two fractionation schedules.

Authors:  R M Huber; R Fischer; H Haŭtmann; B Pöllinger; T Wendt; D Müller-Wening; K Häussinger
Journal:  Chest       Date:  1995-02       Impact factor: 9.410

View more
  1 in total

1.  Cryo-Biopsy versus 19G needle versus 22G needle with EBUS-TBNA endoscopy.

Authors:  Rena Oikonomidou; Dimitris Petridis; Christoforos Kosmidis; Konstantinos Sapalidis; Wolfgang Hohenforst-Schmidt; Vagelis Christakidis; Savas Petanidis; Dimitris Mathaios; Eleni Isidora Perdikouri; Sofia Baka; Christos Tolis; Anastasios Vagionas; Bojan Zaric; Aris Ioannidis; Marios Anemoulis; Konstantinos Porpodis; Vasileios Papadopoulos; Paul Zarogoulidis
Journal:  J Cancer       Date:  2022-08-08       Impact factor: 4.478

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.